← Healthspan Infrastructure research Healthspan · H3 · Prove

Prove stocks

By Scott McLeodPublished by PXS Research Updated October 12, 2026

CROs, clinical trials, real-world evidence and validation systems that turn discoveries into accepted medicine.

6 mapped stocks0 company-level buy signals3 technologies

H3 capability map

Prove technologies

Open a technology to understand the capability, evidence framework and every directly mapped public stock.

AI Drug Discovery & Research Services

12 stocks mapped · Open research GuideCurated

Contract Research Organization (CRO)

0 stocks mapped · Open research Deep Dive

Lab Services & National Diagnostic Networks

2 stocks mapped · Open research

Prove stock picks

CERTCertara Inc.Biosimulation software & services for clinical trial design Prove POOL●●○○○ ●●○○○ $9.46Research target 10/12/26Last reviewed IQVIQVIAFull-service CRO + RWD/RWE data moat Prove HOLD●●●○○ ●●●○○ $309.81Research target 9/17/26Last reviewed CRLCharles River LaboratoriesPreclinical CRO + CGT manufacturing proxy Prove WATCH●●●●● ●●●●● $329.94Research target 9/13/26Last reviewed MEDPMedpaceFull-service CRO, biotech-focused Prove HOLD●●○○○ ●●○○○ $668.47Research target 9/12/26Last reviewed FTREFortreaFull-service CRO, spun from Labcorp — turnaround Prove WATCH●●○○○ ●●○○○ $23.05Research target 8/22/26Last reviewed ICLRICONFull-service CRO with FSP model Prove WATCH●●●●● ●●●●● $185.96Research target 7/8/26Last reviewed

Funds investing in

iShares Biotechnology ETF